K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.21 SEK 0.17% Market Closed
Market Cap: 323.4m SEK
Have any thoughts about
Karolinska Development AB?
Write Note

Karolinska Development AB
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Karolinska Development AB
Cash Equivalents Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
K
Karolinska Development AB
STO:KDEV
Cash Equivalents
kr49.7m
CAGR 3-Years
34%
CAGR 5-Years
35%
CAGR 10-Years
5%
Calliditas Therapeutics AB
STO:CALTX
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash Equivalents
kr2.6B
CAGR 3-Years
83%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash Equivalents
kr170m
CAGR 3-Years
-49%
CAGR 5-Years
34%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Cash Equivalents
kr111.3m
CAGR 3-Years
-26%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash Equivalents
kr882.2m
CAGR 3-Years
23%
CAGR 5-Years
77%
CAGR 10-Years
N/A

See Also

What is Karolinska Development AB's Cash Equivalents?
Cash Equivalents
49.7m SEK

Based on the financial report for Jun 30, 2024, Karolinska Development AB's Cash Equivalents amounts to 49.7m SEK.

What is Karolinska Development AB's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
5%

Over the last year, the Cash Equivalents growth was -58%. The average annual Cash Equivalents growth rates for Karolinska Development AB have been 34% over the past three years , 35% over the past five years , and 5% over the past ten years .

Back to Top